Literature DB >> 26404549

Carcinoma of the oesophagus, with multiple cutaneous metastases.

Rohini Khurana1, Himanshu Mishra1, Kiran Preet Malhotra2, Saumya Shukla2.   

Abstract

A 42-year-old woman was referred, for adjuvant treatment, by an oncosurgeon (outside our centre) after a transhiatal oesophagectomy and gastric pull-up for middle one-third squamous cell carcinoma of the oesophagus pT3N1M0. She underwent adjuvant chemoradiotherapy (CRT) to the tumour bed, regional nodes and scar. RT dose planned was 45 Gy in 25 fractions over 5 weeks. During the second week of RT, a painful nodule was observed over the lower back and cytology was positive for squamous cell carcinoma. Hypofractionated radiotherapy (RT) was planned for this skin nodule as 30 Gy in 10 fractions over 2 weeks using electron beams for pain palliation. Two months later, another nodule developed at the surgical scar on the anterior abdominal wall along with lung and liver metastases. This nodule was also given palliative RT. The patient tolerated the treatment well and had partial pain relief, and, in view of poor prognosis, was advised best supportive care. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26404549      PMCID: PMC4593244          DOI: 10.1136/bcr-2015-211653

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Skin metastasis from an occult esophageal adenocarcinoma.

Authors:  F Fereidooni; K Kovacs; M R Azizi; M Nikoo
Journal:  Can J Gastroenterol       Date:  2005-11       Impact factor: 3.522

3.  Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.

Authors:  Vera Oppedijk; Ate van der Gaast; Jan J B van Lanschot; Pieter van Hagen; Rob van Os; Caroline M van Rij; Maurice J van der Sangen; Jannet C Beukema; Heidi Rütten; Patty H Spruit; Janny G Reinders; Dick J Richel; Mark I van Berge Henegouwen; Maarten C C M Hulshof
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

4.  Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus.

Authors:  G A Bass; H Furlong; K E O'Sullivan; T P J Hennessy; T N Walsh
Journal:  Eur J Cancer       Date:  2014-01-27       Impact factor: 9.162

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.

Authors:  Joel Shapiro; Fiebo J W ten Kate; Pieter van Hagen; Katharina Biermann; Bas P L Wijnhoven; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

7.  Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients.

Authors:  D P Lookingbill; N Spangler; K F Helm
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

8.  Skin metastases in cancer patients.

Authors:  P S Spencer; T N Helm
Journal:  Cutis       Date:  1987-02

9.  Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma.

Authors:  L E Quint; L M Hepburn; I R Francis; R I Whyte; M B Orringer
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

10.  Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis.

Authors:  E P M van Vliet; E W Steyerberg; M J C Eijkemans; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.